Prostate Cancer Lab Meeting #2 - Updates on Patients, Tests, and Treatments
Channel: Cancer Patient Lab
Date: 09/03/2024

Prostate Cancer Lab Meeting #2 Summary
Advanced prostate cancer patients Brian McCloskey and Rick Stanton shared progress in the last week in their testing and treatment research and answered questions about the main activities of the Prostate Cancer Lab:
 
● Gather data: Rick is trying to get access to spatial analysis and apply it to guide his treatment strategy. Rick is working with City of Hope to see whether he can get tissue for sequencing, spatial analysis, and/or an organoid, where Saul Priceman may help. He is also pursuing an IRB-approved workaround with TGen. Lucence is going to run a blood biopsy on Brian. Brian is talking to SEngine about getting an organoid made of his tumor tissue which could be used for testing. Through his relationship with Saul Priceman, Brian has organized a meeting this week with Peter Kuhn, a leader in blood biopsies and testing for prostate cancer.
● Analyze data, find treatment options: Laura Kleiman, founder and CEO at RebootRx, described the research they have been doing to prioritize opportunities to repurpose generic drugs for prostate cancer.
● Define treatment strategy: Rick Davis triggered a conversation focusing on Rick and Brian’s best next treatment, arguing they should try to get access to Pluvicto, a newly-approved prostate cancer drug that binds a radioactive nanoparticle (Lutetium) to antigens which are uniquely on the surface of prostate cancer cells (Prostate-Specific Membrane Antigen).

Session date: March 30, 2022

Full transcript at: https://docs.google.com/document/d/1GRocv-dlFDzTTwsYoli7U89atk58nRHCvJW0VzeImQs/edit?usp=sharing

To learn more visit cancerpatientlab.org

The information and opinions expressed on this website or platform, or during discussions and presentations (both verbal and written) are not intended as health care recommendations or medical advice by Cancer Patient Lab/Prostate Cancer Lab, its principals, presenters, participants, or representatives for any medical treatment, product, or course of action. You should always consult a doctor about your specific situation before pursuing any health care program, treatment, product or other course of action that might affect your health.